Neisseria gonorrhoeae, the microbe responsible for gonorrhoea, is developing resistance to most antibiotics, which means we ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

The WHO has labeled drug-resistant gonorrhea a serious and urgent public health threat. If left untreated, gonorrhea ...

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The ...

New surveillance data from WHO warn of a concerning trend — drug-resistant gonorrhea, which has been a public health concern for years, is surging. Data reported by 12 countries to WHO’s Enhanced ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I given CEFTRIAXONE VIATRIS? CEFTRIAXONE VIATRIS contains ...

Phase 3 findings show oral zoliflodacin to be non-inferior to the combination of ceftriaxone and azithromycin for the ...

GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhoea, according to a phase 3 clinical trial published in The Lancet. The ...

Researchers found use of antimicrobial ceftriaxone was linked to increased risk of vancomycin-resistant enterococci bloodstream infection, according to a study published in Infection Control and ...

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, ...